Keener Financial Planning LLC Has $116,000 Position in UnitedHealth Group Incorporated $UNH

Keener Financial Planning LLC boosted its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 411.0% in the second quarter, according to the company in its most recent disclosure with the SEC. The firm owned 373 shares of the healthcare conglomerate’s stock after purchasing an additional 300 shares during the quarter. Keener Financial Planning LLC’s holdings in UnitedHealth Group were worth $116,000 as of its most recent SEC filing.

A number of other institutional investors have also recently bought and sold shares of UNH. Brighton Jones LLC grew its holdings in UnitedHealth Group by 176.2% during the fourth quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate’s stock valued at $22,384,000 after purchasing an additional 28,231 shares during the period. Revolve Wealth Partners LLC boosted its holdings in shares of UnitedHealth Group by 137.1% in the fourth quarter. Revolve Wealth Partners LLC now owns 4,019 shares of the healthcare conglomerate’s stock valued at $2,033,000 after buying an additional 2,324 shares during the period. GAMMA Investing LLC boosted its holdings in shares of UnitedHealth Group by 7.4% in the first quarter. GAMMA Investing LLC now owns 15,838 shares of the healthcare conglomerate’s stock valued at $8,295,000 after buying an additional 1,089 shares during the period. West Branch Capital LLC boosted its holdings in shares of UnitedHealth Group by 4.6% in the first quarter. West Branch Capital LLC now owns 11,689 shares of the healthcare conglomerate’s stock valued at $6,122,000 after buying an additional 519 shares during the period. Finally, Powers Advisory Group LLC boosted its holdings in shares of UnitedHealth Group by 9.8% in the first quarter. Powers Advisory Group LLC now owns 461 shares of the healthcare conglomerate’s stock valued at $242,000 after buying an additional 41 shares during the period. Institutional investors and hedge funds own 87.86% of the company’s stock.

UnitedHealth Group Stock Performance

Shares of UNH stock opened at $354.30 on Friday. The stock has a market cap of $320.88 billion, a P/E ratio of 15.35, a P/E/G ratio of 2.29 and a beta of 0.47. The company has a debt-to-equity ratio of 0.73, a current ratio of 0.85 and a quick ratio of 0.85. The company has a fifty day moving average price of $318.21 and a two-hundred day moving average price of $349.25. UnitedHealth Group Incorporated has a one year low of $234.60 and a one year high of $630.73.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 EPS for the quarter, missing analysts’ consensus estimates of $4.45 by ($0.37). UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The firm had revenue of $111.62 billion during the quarter, compared to analyst estimates of $111.75 billion. During the same quarter in the prior year, the business earned $6.80 EPS. The business’s revenue was up 12.9% compared to the same quarter last year. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. As a group, equities analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Tuesday, September 23rd. Shareholders of record on Monday, September 15th were issued a $2.21 dividend. This represents a $8.84 annualized dividend and a yield of 2.5%. The ex-dividend date of this dividend was Monday, September 15th. UnitedHealth Group’s dividend payout ratio (DPR) is currently 38.30%.

Analyst Ratings Changes

Several research firms have recently weighed in on UNH. Truist Financial upped their price target on shares of UnitedHealth Group from $310.00 to $365.00 and gave the company a “buy” rating in a report on Tuesday, September 9th. KeyCorp increased their target price on shares of UnitedHealth Group from $350.00 to $400.00 and gave the stock an “overweight” rating in a report on Wednesday. JPMorgan Chase & Co. increased their target price on shares of UnitedHealth Group from $310.00 to $425.00 and gave the stock an “overweight” rating in a report on Thursday. Sanford C. Bernstein increased their target price on shares of UnitedHealth Group from $379.00 to $433.00 and gave the stock an “outperform” rating in a report on Wednesday. Finally, Wells Fargo & Company increased their target price on shares of UnitedHealth Group from $267.00 to $400.00 and gave the stock an “overweight” rating in a report on Tuesday, October 7th. Sixteen research analysts have rated the stock with a Buy rating, seven have given a Hold rating and four have given a Sell rating to the company’s stock. Based on data from MarketBeat.com, UnitedHealth Group currently has an average rating of “Hold” and a consensus target price of $383.09.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.